Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
25 Apr 24
8-K
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
25 Apr 24
DEFA14A
Additional proxy soliciting materials
22 Apr 24
ARS
2023 FY
Annual report to shareholders
28 Mar 24
DEFA14A
Additional proxy soliciting materials
28 Mar 24
DEF 14A
Definitive proxy
28 Mar 24
8-K
Departure of Directors or Certain Officers
18 Mar 24
PRE 14A
Preliminary proxy
18 Mar 24
8-K
Strengthening Neuroscience Portfolio
18 Mar 24
SC TO-T/A
Third party tender offer statement (amended)
23 Feb 24
8-K
Other Events
22 Feb 24
424B5
Prospectus supplement for primary offering
16 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
16 Feb 24
8-K
Departure of Directors or Certain Officers
15 Feb 24
FWP
Free writing prospectus
14 Feb 24
8-K
Bristol Myers Squibb Recommends Stockholders Reject “Mini-Tender” Offer by Tutanota LLC
14 Feb 24
10-K
2023 FY
Annual report
13 Feb 24
424B2
Prospectus for primary offering
13 Feb 24
SC TO-T/A
Third party tender offer statement (amended)
12 Feb 24
8-K
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
2 Feb 24
SC TO-T
Third party tender offer statement
25 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
SC TO-C
Information about tender offer
26 Dec 23
DFAN14A
Additional proxy materials by non-management
22 Dec 23
DFAN14A
Additional proxy materials by non-management
22 Dec 23
8-K
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
22 Dec 23
8-K
Other Events
13 Nov 23
424B5
Prospectus supplement for primary offering
1 Nov 23
8-K/A
Departure of Directors or Certain Officers
31 Oct 23
FWP
Free writing prospectus
30 Oct 23
424B3
Prospectus supplement
30 Oct 23
10-Q
2023 Q3
Quarterly report
26 Oct 23
8-K
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
26 Oct 23
DFAN14A
Additional proxy materials by non-management
10 Oct 23
8-K
Other Events
10 Aug 23
10-Q
2023 Q2
Quarterly report
27 Jul 23
8-K
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
27 Jul 23
8-K
Departure of Directors or Certain Officers
4 May 23
10-Q
2023 Q1
Quarterly report
27 Apr 23
8-K
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
27 Apr 23
Latest ownership filings
4
Karin Shanahan
2 Apr 24
4
PHYLLIS R YALE
2 Apr 24
4
Gerald L Storch
2 Apr 24
4
Theodore R. Samuels II
2 Apr 24
4
Derica W Rice
2 Apr 24
4
Deepak Bhatt
2 Apr 24
4
Peter J Arduini
2 Apr 24
4
Adam Lenkowsky
12 Mar 24
4
SANDRA LEUNG
12 Mar 24
4
Robert M Plenge
12 Mar 24
4
Ahn Amanda Poole
12 Mar 24
4
Samit Hirawat
12 Mar 24
4
Phil M Holzer
12 Mar 24
4
Lynelle Hoch
12 Mar 24
4
Cari Gallman
12 Mar 24
4
CHRISTOPHER S. BOERNER
12 Mar 24
4
Karin Shanahan
12 Mar 24
4
Gregory Scott Meyers
12 Mar 24
4
Benjamin Hickey
12 Mar 24
4
David V Elkins
12 Mar 24
4
Giovanni Caforio
12 Mar 24
4
Benjamin Hickey
4 Mar 24
3
Benjamin Hickey
4 Mar 24
3
Phil M Holzer
23 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
4
PHYLLIS R YALE
5 Feb 24
4
Gerald L Storch
5 Feb 24
4
Karen H Vousden
5 Feb 24
4
Theodore R. Samuels II
5 Feb 24
4
Derica W Rice
5 Feb 24
4
Paula A Price
5 Feb 24
4
Medina Manuel Hidalgo
5 Feb 24
4
Julia A Haller
5 Feb 24
4
Deepak Bhatt
5 Feb 24
4
Peter J Arduini
5 Feb 24
4
Gregory Scott Meyers
5 Feb 24
SC 13G/A
BlackRock Inc.
25 Jan 24
3
Ahn Amanda Poole
3 Jan 24
4
PHYLLIS R YALE
3 Jan 24
4
Gerald L Storch
3 Jan 24